A study in this issue presents a new mouse model that directly tests the glutamate hypothesis of schizophrenia. The study reports that a decrease in NMDA receptor signaling during a particular developmental window in interneurons can induce cellular and behavioral changes similar to those seen in schizophrenia.
References
Belforte, J.E. et al. Nat. Neurosci. 13, 76–83 (2010).
Krystal, J.H., Anand, A. & Moghaddam, B. Arch. Gen. Psychiatry 59, 663–664 (2002).
Coyle, J.T. Cell. Mol. Neurobiol. 26, 365–384 (2006).
Lisman, J.E. et al. Trends Neurosci. 31, 234–242 (2008).
Lewis, D.A. & Moghaddam, B. Arch. Neurol. 63, 1372–1376 (2006).
Benes, F.M. & Berretta, S. Neuropsychopharmacology 25, 1–27 (2001).
Halene, T.B. et al. Genes Brain Behav. 8, 661–675 (2009).
Duncan, G.E. et al. Behav. Brain Res. 153, 507–519 (2004).
Houthoofd, S.A., Morrens, M. & Sabbe, B.G. Clin. Ther. 30, 1565–1589 (2008).
Reilly, J.L., Harris, M.S., Keshavan, M.S. & Sweeney, J.A. Arch. Gen. Psychiatry 63, 1189–1197 (2006).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gordon, J. Testing the glutamate hypothesis of schizophrenia. Nat Neurosci 13, 2–4 (2010). https://doi.org/10.1038/nn0110-2
Issue Date:
DOI: https://doi.org/10.1038/nn0110-2
- Springer Nature America, Inc.
This article is cited by
-
Functional connectivity signatures of NMDAR dysfunction in schizophrenia—integrating findings from imaging genetics and pharmaco-fMRI
Translational Psychiatry (2023)
-
Transcranial Ultrasound Stimulation Reverses Behavior Changes and the Expression of Calcium-Binding Protein in a Rodent Model of Schizophrenia
Neurotherapeutics (2022)
-
Electrophysiological evidence for abnormal glutamate-GABA association following psychosis onset
Translational Psychiatry (2018)
-
Altered expression of schizophrenia-related genes in mice lacking mGlu5 receptors
European Archives of Psychiatry and Clinical Neuroscience (2018)
-
Mice Lacking the Serotonin Htr2B Receptor Gene Present an Antipsychotic-Sensitive Schizophrenic-Like Phenotype
Neuropsychopharmacology (2015)